We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
As we begin to head into the summer months, one thing remains undeniable: stocks have been much stronger in 2023 compared to last year’s rough showing, undoubtedly a welcomed development.
Many stocks have rebounded in a big way so far, with some breaking out to new 52-week highs, including Novo Nordisk (NVO - Free Report) , Lamb Weston (LW - Free Report) , and Radian Group (RDN - Free Report) . Below is a chart illustrating the performance of all three in 2023, with the S&P 500 blended in as a benchmark.
Image Source: Zacks Investment Research
As we can see, all three have displayed considerable momentum year-to-date, crushing the S&P 500’s impressive 9% gain. For those interested in riding the relative strength, let’s take a closer look at each.
Lamb Weston
Lamb Weston is a leading global manufacturer, marketer, and distributor of value-added frozen potato products. The stock is presently a Zacks Rank #1 (Strong Buy).
Image Source: Zacks Investment Research
LW has consistently posted strong quarterly results as of late, exceeding the Zacks Consensus EPS Estimate by double-digit percentages in six consecutive quarters. Just in its latest release, Lamb Weston registered a 46% EPS beat and reported revenue 6.5% above expectations.
Image Source: Zacks Investment Research
Investors could use the 50-day moving average as a potential entry point, as the level has consistently provided support over the last year. This is illustrated in the chart below.
Image Source: Zacks Investment Research
Novo Nordisk
Novo Nordisk is a global healthcare company and a leader in the worldwide diabetes market. As we can see below, analysts have increased their earnings expectations over the last several months, helping land the stock into a Zacks Rank #1 (Strong Buy).
Image Source: Zacks Investment Research
In addition, NVO shares are expensive on a relative basis, with the current 34.6X forward earnings multiple sitting well above the 24.4X five-year median and the Zacks Medical sector average. The steep valuation picture could cause some selling pressure, a development investors should be highly aware of.
Image Source: Zacks Investment Research
If shares see a correction, expect the 50-day moving average to become an area of interest, a level that shares have recently bounced off of.
Image Source: Zacks Investment Research
Radian Group
Radian Group, a credit enhancement company, supports homebuyers, mortgage lenders, loan servicers, and investors with a suite of private mortgage insurance and related risk-management products and services. Like the stocks above, RDN sports the highly-coveted Zacks Rank #1 (Strong Buy).
Shares don’t appear stretched in terms of valuation, with the current 7.6X forward earnings multiple sitting a few ticks below the five-year median and the Zacks Finance sector average.
The stock carries a Style Score of “B” for Value.
Image Source: Zacks Investment Research
In addition, shares do pay a solid dividend, currently yielding 3.6% annually. Impressively, the company has more than doubled its payout over the last years, fully reflecting a commitment to increasingly rewarding its shareholders.
Image Source: Zacks Investment Research
Shares are now breaking out of a several-year-long range, as we can see illustrated below. Previously, RDN shares have failed to hold their momentum at this level, but the company’s improved earnings outlook could fuel shares well above.
Image Source: Zacks Investment Research
Bottom Line
Momentum investing is centered around targeting stocks displaying outperformance. And when you add in the Zacks Rank, the strategy can become even more powerful.
And that’s precisely what all three stocks above – Novo Nordisk (NVO - Free Report) , Lamb Weston (LW - Free Report) , and Radian Group (RDN - Free Report) – have displayed, breaking out to new 52-week highs on the back of improved earnings outlooks.
Still, it’s essential for investors to carefully place stop losses at comfortable thresholds, as the momentum swing can quickly turn negative.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Don't Ignore the Momentum in These 3 Stocks
As we begin to head into the summer months, one thing remains undeniable: stocks have been much stronger in 2023 compared to last year’s rough showing, undoubtedly a welcomed development.
Many stocks have rebounded in a big way so far, with some breaking out to new 52-week highs, including Novo Nordisk (NVO - Free Report) , Lamb Weston (LW - Free Report) , and Radian Group (RDN - Free Report) . Below is a chart illustrating the performance of all three in 2023, with the S&P 500 blended in as a benchmark.
Image Source: Zacks Investment Research
As we can see, all three have displayed considerable momentum year-to-date, crushing the S&P 500’s impressive 9% gain. For those interested in riding the relative strength, let’s take a closer look at each.
Lamb Weston
Lamb Weston is a leading global manufacturer, marketer, and distributor of value-added frozen potato products. The stock is presently a Zacks Rank #1 (Strong Buy).
Image Source: Zacks Investment Research
LW has consistently posted strong quarterly results as of late, exceeding the Zacks Consensus EPS Estimate by double-digit percentages in six consecutive quarters. Just in its latest release, Lamb Weston registered a 46% EPS beat and reported revenue 6.5% above expectations.
Image Source: Zacks Investment Research
Investors could use the 50-day moving average as a potential entry point, as the level has consistently provided support over the last year. This is illustrated in the chart below.
Image Source: Zacks Investment Research
Novo Nordisk
Novo Nordisk is a global healthcare company and a leader in the worldwide diabetes market. As we can see below, analysts have increased their earnings expectations over the last several months, helping land the stock into a Zacks Rank #1 (Strong Buy).
Image Source: Zacks Investment Research
In addition, NVO shares are expensive on a relative basis, with the current 34.6X forward earnings multiple sitting well above the 24.4X five-year median and the Zacks Medical sector average. The steep valuation picture could cause some selling pressure, a development investors should be highly aware of.
Image Source: Zacks Investment Research
If shares see a correction, expect the 50-day moving average to become an area of interest, a level that shares have recently bounced off of.
Image Source: Zacks Investment Research
Radian Group
Radian Group, a credit enhancement company, supports homebuyers, mortgage lenders, loan servicers, and investors with a suite of private mortgage insurance and related risk-management products and services. Like the stocks above, RDN sports the highly-coveted Zacks Rank #1 (Strong Buy).
Shares don’t appear stretched in terms of valuation, with the current 7.6X forward earnings multiple sitting a few ticks below the five-year median and the Zacks Finance sector average.
The stock carries a Style Score of “B” for Value.
Image Source: Zacks Investment Research
In addition, shares do pay a solid dividend, currently yielding 3.6% annually. Impressively, the company has more than doubled its payout over the last years, fully reflecting a commitment to increasingly rewarding its shareholders.
Image Source: Zacks Investment Research
Shares are now breaking out of a several-year-long range, as we can see illustrated below. Previously, RDN shares have failed to hold their momentum at this level, but the company’s improved earnings outlook could fuel shares well above.
Image Source: Zacks Investment Research
Bottom Line
Momentum investing is centered around targeting stocks displaying outperformance. And when you add in the Zacks Rank, the strategy can become even more powerful.
And that’s precisely what all three stocks above – Novo Nordisk (NVO - Free Report) , Lamb Weston (LW - Free Report) , and Radian Group (RDN - Free Report) – have displayed, breaking out to new 52-week highs on the back of improved earnings outlooks.
Still, it’s essential for investors to carefully place stop losses at comfortable thresholds, as the momentum swing can quickly turn negative.